BGI
CLLS

B Group Inc’s Cellectis CLLS Stock Holding History

B Group Inc’s Portfolio CLLS Stock Details CLLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$10.4M Hold
3,281,501
– – 7.71% 4
2025
Q4 		$15.9M Hold
3,281,501
– – 11.73% 2
2025
Q3 		$9.35M Buy
3,281,501
+25,000
+0.8% +$64.8K 6.88% 6
2025
Q2 		$4.97M Hold
3,256,501
– – 3.82% 6
2025
Q1 		$4.04M Buy
3,256,501
+175,000
+6% +$259K 3.46% 6
2024
Q4 		$5.55M Buy
+3,081,501
New +$5.75M 3.39% 7

Other funds holding CLLS

UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.8B AUM 7.31% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $58.4B AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

B Group Inc's CLLS Position: Q1 2026 in Review

B Group Inc held its Cellectis (CLLS) position steady in Q1 2026 at 3,281,501 shares worth $10.4M. The position accounts for 7.71% of the portfolio, ranked #4.

B Group Inc first reported a position in CLLS in Q4 2024 and has held it in 6 quarters since. The position peaked at $15.9M in Q4 2025. 32 funds tracked by Wall St. Rank hold CLLS as of Q1 2026.

  • B Group Inc held 3,281,501 shares of Cellectis worth $10.4M as of Q1 2026.
  • B Group Inc left its Cellectis share count unchanged in Q1 2026.
  • Cellectis made up 7.71% of B Group Inc's portfolio in Q1 2026, its #4 holding.
  • B Group Inc first reported a position in Cellectis in Q4 2024 and has held it in 6 quarters since.
  • B Group Inc's Cellectis position peaked at $15.9M in Q4 2025.
  • 32 funds tracked by Wall St. Rank held Cellectis as of Q1 2026.

Based on B Group Inc's 13F filing for Q1 2026, filed 15 May 2026.